Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02735876
Brief Title: A Study of Acalabrutinib in Combination With Rituximab Versus Ibrutinib Versus Acalabrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

First Submitted : April 8, 2016
First Submitted that Met QC Criteria : April 8, 2016
First Posted : April 13, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 12, 2016
Last Update Posted : May 13, 2016 (Estimate)